Cas:5845-53-4 Methyl D-leucinate hydrochloride (1:1) manufacturer & supplier

Chemical Name:Methyl D-leucinate hydrochloride (1:1)

CAS.NO:5845-53-4

Synonyms:Methyl D-leucinate hydrochloride (1:1);[(2R)-1-methoxy-4-methyl-1-oxopentan-2-yl]azanium;MFCD00066115;D-Leucine, methyl ester, hydrochloride (1:1);D-LEUCINE METHYL ESTER HYDROCHLORIDE SALT

Molecular Formula:C₇H₁₆ClNO₂

Molecular Weight:181.660

HS Code:2922499990

Physical and Chemical Properties:

Melting point:150ºC

Boiling point:169.2ºC at 760 mmHg

Density:0.955g/cm3

Index of Refraction:

PSA:52.32000

Exact Mass:181.086960

LogP:2.03510

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Methyl D-leucinate hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,D-LEUCINE METHYL ESTER HYDROCHLORIDE SALT physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00066115 Use and application,MFCD00066115 technical grade,usp/ep/jp grade.

Related News: With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. Methyl D-leucinate hydrochloride (1:1) manufacturer The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market. Methyl D-leucinate hydrochloride (1:1) supplier The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market. Methyl D-leucinate hydrochloride (1:1) vendor With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. Methyl D-leucinate hydrochloride (1:1) factory Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue.